Other Headlines

Former Trade Desk pro from Siemens joins the DOTmed 100 company.
Two Idaho clinics are the latest to install NovaRad's NovaPACS to improve workflow and ease image access for interpreting and referring physicians.
The Institute of Cancer Research has found that women with breast cancer had more manageable side effects when their radiotherapy was delivered in larger - but fewer - doses.
On-pump and off-pump bypass surgery yield similar results, reports the Harvard Heart Letter.
Research on traumatic brain injury will be used to determine faster treatment, safer vehicles.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More Industry Headlines

New Research Study Will Use fMRIs to Examine Soldiers' TBIs Research on traumatic brain injury will be used to determine faster treatment, safer vehicles.

Congress Submits Bill to Repeal Antitrust Exemption Reform measure would end exemption for health care, medical malpractice insurance.

FDA Issues Guidance on Facilitating Medical Device Clinical Trials Agency suggests statistical methods for cost and streamlining.

White House to Convene Health Meeting President Obama promised a bipartisan event Feb. 25.

Las Vegas Spine Surgeon Pleads Guilty to Misprision of Felony A federal case review from the pages of DOTmed Business News.

Philips Inks Three-Year Deal With SunCrest Philips' telemedicine division inked a three-year deal with the Sun Belt home care system SunCrest Healthcare, Inc.

HHS Highlights Health Care Investments in New Budget Budget includes health IT, research, public health measures.

FDA Wants $4 Billion to Overhaul Medical Device, Food Safety Monitoring The injections of new cash could help establish a registry for medical devices and create over 1,000 new jobs.

Colorado Physicians Group Settles With FTC Over Alleged Price-Fixing Group accused of anti-competitive tactics against health insurers.

NIH Discusses Dose Monitoring Program DOTmed News spoke with Dr. David Bluemke of the National Institutes of Health about the new program to require radiation dose monitoring on all equipment purchased by the NIH's Clinical Center.

Gold may one day play
a role in devices
for drug delivery

Gold Particles Deliver More Than Just Glitter

by Lynn Shapiro, Writer
Using tiny gold particles and infrared light, MIT researchers have developed a drug-delivery system that allows multiple drugs to be released in a controlled fashion. Such a system could one day be used to provide more control when battling diseases commonly treated with more than one drug, according to the researchers.

"With a lot of diseases, especially cancer and AIDS, you get a synergistic effect with more than one drug," said Kimberly Hamad-Schifferli, assistant professor of biological and mechanical engineering and senior author of a paper on the work that recently appeared in the journal ACS Nano.

Delivery devices already exist that can release two drugs, but the timing of the release must be built into the device -- it cannot be controlled from outside the body. The new system is controlled externally and theoretically could deliver up to three or four drugs. The new technique takes advantage of the fact that when gold nanoparticles are exposed to infrared light, they melt and release drug payloads attached to their surfaces.

Nanoparticles of different shapes respond to different infrared wavelengths, so "just by controlling the infrared wavelength, we can choose the release time" for each drug, said Andy Wijaya, graduate student in chemical engineering and lead author of the paper.

The team built two different shapes of nanoparticles, which they call "nanobones" and "nanocapsules." Nanobones melt at light wavelengths of 1,100 nanometers, and nanocapsules at 800 nanometers. In the ACS Nano study, the researchers tested the particles with a payload of DNA. Each nanoparticle can carry hundreds of strands of DNA, and could also be engineered to transport other types of drugs.

In theory, up to four differently shaped particles could be developed, each releasing its payload at different wavelengths.

Other authors of the paper are Stefan Schaffer and Ivan Pallares, who were National Science Foundation REU (Research Experiences for Undergraduates) summer students through the MIT Department of Biological Engineering in 2008.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2010 DOTmed.com, Inc.
ALL RIGHTS RESERVED